White Paper

Random Integration vs. Semi-Targeted Integration In Stable Cell Line Development

Source: Abzena
GettyImages-1294339649 drug development, cleanroom

Trying to decide what integration method is best for your cell line development (CLD) program? Comparing random integration with semi-targeted (i.e. Transposase) integration side by side, this whitepaper demonstrates that clones developed using random integration often result in higher expression levels, improved growth characteristics, and superior process robustness compared to semi-targeted systems. While semi-targeted approaches may offer precision, they may fall short in overall efficiency and productivity — especially in late-stage manufacturing.

If you're selecting an integration method for your CLD program, download this whitepaper today to access data-backed insights to inform a more confident, future-proofed decision.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online